









Markets
/
Stocks
/
nasdaq-prct
/

Procept Biorobotics Corp

PRCT

View Detailed Chart

57.040USD

-0.970-1.67%

Close 07/16, 16:00（ET）Quotes delayed by 15 min

3.15BMarket Cap

LossP/E TTM



Procept Biorobotics Corp

57.040

-0.970-1.67%

Overview Company Financials

Financials

Intraday

30m

Today

-1.67%

5 Days

-2.43%

1 Month

-5.56%

6 Months

-27.65%

Year to Date

-29.16%

1 Year

-18.23%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 13 analysts

BUY

Current Rating

77.200

Target Price

33.08%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

Procept Biorobotics Corp

PRCT

Medtronic PLC

MDT

Stryker Corp

SYK

Zimmer Biomet Holdings Inc

ZBH

Abbott Laboratories

ABT

Dexcom Inc

DXCM

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(10)

Neutral(3)

Buy(0)

Indicators

Sell(4)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.219

Sell

RSI(14)

45.519

Neutral

STOCH(KDJ)(9,3,3)

49.598

Neutral

ATR(14)

2.396

High Vlolatility

CCI(14)

-50.888

Neutral

Williams %R

55.413

Sell

TRIX(12,20)

-0.136

Sell

StochRSI(14)

19.042

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

57.816

Sell

MA10

57.852

Sell

MA20

58.151

Sell

MA50

58.203

Sell

MA100

57.810

Sell

MA200

69.719

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Ticker SymbolPRCT

CompanyProcept Biorobotics Corp

CEODr. Reza Zadno, Ph.D.

Websitehttps://www.procept-biorobotics.com/